Cepheid Inc (Cepheid), a subsidiary of Danaher Corp, is a molecular diagnostic company that develops, manufactures, and markets molecular systems and conducts tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious diseases, sexual health, virology, oncology and genetics; molecular diagnostic systems; and reagents and parts. Cepheid distributes its products directly and through a network of distributors present across the Americas, Asia, Europe, Africa and the Middle East. The company also offers various services such as maintenance, software updates, repair, and support among others. Cepheid is headquartered in Sunnyvale, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cepheid Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Cepheid Inc Company Overview
- Cepheid Inc Company Snapshot
- Cepheid Inc Pipeline Products and Ongoing Clinical Trials Overview
- Cepheid Inc - Pipeline Analysis Overview
- Business Description
- Cepheid Inc - Key Facts
- Cepheid Inc - Major Products and Services
- Cepheid Inc Pipeline Products by Development Stage
- Cepheid Inc Ongoing Clinical Trials by Trial Status
- Cepheid Inc Pipeline Products Overview
- Breast Cancer Detection Assay
- Breast Cancer Detection Assay Product Overview
- GeneXpert - Xpert HPV CLIA Waived
- GeneXpert - Xpert HPV CLIA Waived Product Overview
- GeneXpert Omni - Flu/RSV CW
- GeneXpert Omni - Flu/RSV CW Product Overview
- GeneXpert Omni - HCV Viral Load
- GeneXpert Omni - HCV Viral Load Product Overview
- GeneXpert Omni - HIV-1 Qualitative Test
- GeneXpert Omni - HIV-1 Qualitative Test Product Overview
- GeneXpert Omni - HIV-1 Viral Load Test
- GeneXpert Omni - HIV-1 Viral Load Test Product Overview
- GeneXpert Omni - MTB/RIF
- GeneXpert Omni - MTB/RIF Product Overview
- GeneXpert Omni - Xpert CT/NG
- GeneXpert Omni - Xpert CT/NG Product Overview
- GeneXpert Omni - Xpert HPV
- GeneXpert Omni - Xpert HPV Product Overview
- GeneXpert Omni - Xpert HPV CLIA Waived
- GeneXpert Omni - Xpert HPV CLIA Waived Product Overview
- GeneXpert Omni - Xpert MTB/RIF Ultra
- GeneXpert Omni - Xpert MTB/RIF Ultra Product Overview
- GeneXpert Omni - Xpert MTB/RIF Ultra Clinical Trial
- GeneXpert Omni - Xpress CT/NG CW
- GeneXpert Omni - Xpress CT/NG CW Product Overview
- GeneXpert Omni - Xpress Flu CW
- GeneXpert Omni - Xpress Flu CW Product Overview
- GeneXpert Omni - Xpress Flu/RSV CW
- GeneXpert Omni - Xpress Flu/RSV CW Product Overview
- GeneXpert Omni - Xpress GAS CW
- GeneXpert Omni - Xpress GAS CW Product Overview
- GeneXpert Omni - Xpress GBS Ultra CW
- GeneXpert Omni - Xpress GBS Ultra CW Product Overview
- GeneXpert Omni - Xpress Pertussis CW
- GeneXpert Omni - Xpress Pertussis CW Product Overview
- GeneXpert Omni - Xpress Vag/Vag
- GeneXpert Omni - Xpress Vag/Vag Product Overview
- GeneXpert Omni - Xpress Vaginitis/Vaginosis CW
- GeneXpert Omni - Xpress Vaginitis/Vaginosis CW Product Overview
- GeneXpert Tropical Fever Panel
- GeneXpert Tropical Fever Panel Product Overview
- Mycology Panel Assay
- Mycology Panel Assay Product Overview
- POC Catridge - Viral Hemorrhagic Fever
- POC Catridge - Viral Hemorrhagic Fever Product Overview
- POC Test - Viral Hemorrhagic Fever
- POC Test - Viral Hemorrhagic Fever Product Overview
- Point Of Care Test - Fungi Infections
- Point Of Care Test - Fungi Infections Product Overview
- Urine Based Screening Test - Cervical Cancer
- Urine Based Screening Test - Cervical Cancer Product Overview
- Xpert 2C19 Assay
- Xpert 2C19 Assay Product Overview
- Xpert BCR-ABL Ultra - Acute Lymphocytic Leukemia
- Xpert BCR-ABL Ultra - Acute Lymphocytic Leukemia Product Overview
- Xpert BCR-ABL Ultra - Acute Myeloid Leukemia
- Xpert BCR-ABL Ultra - Acute Myeloid Leukemia Product Overview
- Xpert BCR-ABL Ultra - Solid Tumors
- Xpert BCR-ABL Ultra - Solid Tumors Product Overview
- Xpert BKV Assay
- Xpert BKV Assay Product Overview
- Xpert Bladder Cancer Asymptomatic Assay
- Xpert Bladder Cancer Asymptomatic Assay Product Overview
- Xpert Bladder Cancer Symptomatic Assay
- Xpert Bladder Cancer Symptomatic Assay Product Overview
- Xpert Breast CA Monitoring Test
- Xpert Breast CA Monitoring Test Product Overview
- Xpert Breast CA Prognostic Signature Assay
- Xpert Breast CA Prognostic Signature Assay Product Overview
- Xpert Breast CA Resistance Monitoring Test
- Xpert Breast CA Resistance Monitoring Test Product Overview
- Xpert Carba-R NxG Test
- Xpert Carba-R NxG Test Product Overview
- Xpert CLL Monitoring Test
- Xpert CLL Monitoring Test Product Overview
- Xpert CMV Quant Assay
- Xpert CMV Quant Assay Product Overview
- Xpert CMV Viral Load Assay
- Xpert CMV Viral Load Assay Product Overview
- Xpert CT/NG FluroQ Resistant Trichomonas Assay
- Xpert CT/NG FluroQ Resistant Trichomonas Assay Product Overview
- Xpert CT/NG LBC Assay
- Xpert CT/NG LBC Assay Product Overview
- Xpert EBV Quant Assay
- Xpert EBV Quant Assay Product Overview
- Xpert Ebv/Npc Monitor
- Xpert Ebv/Npc Monitor Product Overview
- Xpert Ebv/Npc Screen
- Xpert Ebv/Npc Screen Product Overview
- Xpert EGFR Monitor (Lung) Test
- Xpert EGFR Monitor (Lung) Test Product Overview
- Xpert GBS Ultra
- Xpert GBS Ultra Product Overview
- Xpert Gi Panel Assay
- Xpert Gi Panel Assay Product Overview
- Xpert Group A Strep Assay
- Xpert Group A Strep Assay Product Overview
- Xpert Group A/C Strep Assay
- Xpert Group A/C Strep Assay Product Overview
- Xpert Hcv Quant Assay
- Xpert Hcv Quant Assay Product Overview
- Xpert HIV Quant Assay
- Xpert HIV Quant Assay Product Overview
- Xpert HSV CSF Assay
- Xpert HSV CSF Assay Product Overview
- Xpert Insight Breast Cancer
- Xpert Insight Breast Cancer Product Overview
- Xpert Lung CA Early Detection Test
- Xpert Lung CA Early Detection Test Product Overview
- Xpert Meningitis/Encephalitis Assay
- Xpert Meningitis/Encephalitis Assay Product Overview
- Xpert Microbial ID Assay
- Xpert Microbial ID Assay Product Overview
- Xpert Next Generation MRSA/SA SSTI Assay
- Xpert Next Generation MRSA/SA SSTI Assay Product Overview
- Xpert Next Generation SA Nasal Complete Assay
- Xpert Next Generation SA Nasal Complete Assay Product Overview
- Xpert OncoScreen Lung Cancer Assay
- Xpert OncoScreen Lung Cancer Assay Product Overview
- Xpert Pancreatic CA Early Detection Test
- Xpert Pancreatic CA Early Detection Test Product Overview
- Xpert Pancreatic CA Monitor Assay
- Xpert Pancreatic CA Monitor Assay Product Overview
- Xpert Pertussis Assay
- Xpert Pertussis Assay Product Overview
- Xpert Prostate CA Early Detection Test
- Xpert Prostate CA Early Detection Test Product Overview
- Xpert Prostate Cancer Recurrence Risk Test
- Xpert Prostate Cancer Recurrence Risk Test Product Overview
- Xpert Respiratory Panel
- Xpert Respiratory Panel Product Overview
- Xpert RSV/Metapneumovirus Assay
- Xpert RSV/Metapneumovirus Assay Product Overview
- Xpert Sepsis Fungal Assay
- Xpert Sepsis Fungal Assay Product Overview
- Xpert Vaginitis Assay
- Xpert Vaginitis Assay Product Overview
- Xpert VAP Gram Negative Assay
- Xpert VAP Gram Negative Assay Product Overview
- Xpert VZV Assay
- Xpert VZV Assay Product Overview
- Xpress Strep A Assay
- Xpress Strep A Assay Product Overview
- Cepheid Inc - Key Competitors
- Cepheid Inc - Key Employees
- Cepheid Inc - Key Employee Biographies
- Cepheid Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Cepheid Inc, Recent Developments
- Mar 31, 2020: AdvaMed: COVID-19 test availability rapidly scales up
- Feb 28, 2020: Cepheid and Sherlock Biosciences establish collaboration on new GeneXpert tests for infectious diseases and oncology leveraging CRISPR technology
- Feb 28, 2020: Cepheid and Sherlock Biosciences establish collaboration on new GeneXpert tests for infectious diseases and oncology leveraging CRISPR technology
- Feb 11, 2020: Cepheid to develop automated molecular test for coronavirus
- Feb 11, 2020: Cepheid to develop automated molecular test for coronavirus
- Dec 16, 2019: European launch of resistanceplus MG fleXible for the GeneXpert System
- Oct 02, 2019: Cepheid Receives FDA Clearance for Xpert BCR-ABL Ultra Test
- Jun 10, 2019: Xpert Ultra test for diagnosing TB now included in Cochrane Review
- May 29, 2019: Cepheid receives FDA clearance for extragenital claims for Xpert CT/NG test
- May 24, 2019: FDA clears diagnostic tests for chlamydia and gonorrhoea
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Cepheid Inc Pipeline Products and Ongoing Clinical Trials Overview
- Cepheid Inc Pipeline Products by Equipment Type
- Cepheid Inc Pipeline Products by Indication
- Cepheid Inc Ongoing Clinical Trials by Trial Status
- Cepheid Inc, Key Facts
- Cepheid Inc, Major Products and Services
- Cepheid Inc Number of Pipeline Products by Development Stage
- Cepheid Inc Pipeline Products Summary by Development Stage
- Cepheid Inc Ongoing Clinical Trials by Trial Status
- Ce
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Binx Health Inc
- Luminex Corp
- Hologic Inc
- Meridian Bioscience Inc
- GenMark Diagnostics Inc
